{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:29:31Z","timestamp":1777429771584,"version":"3.51.4"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11]]},"abstract":"<jats:p>In this review, we report the available data regarding efficacy, safety and pharmacokinetics of colistin in the treatment of multidrug-resistant Gram-negative bacteria in neonates and infants. Seventeen clinical studies, involving 312 patients, and 3 pharmacokinetics studies were identified. Blood stream infection was the most common source of infection, followed by pneumonia and meningitis\/ventriculitis. In most cases, colistin was administered in association with other antibiotics. The most common route of administration was intravenous, with colistimethate doses ranging from 25,000 to 225,000 IU\/kg\/day divided into 2 or 3 doses. A recent pharmacokinetic study suggested that the appropriate intravenous dose should be &gt;150,000 IU\/kg\/day. Microbiologic cure was obtained in 94.2% of patients and survival was 76.6%. The combination of intraventricular and intravenous colistin should be used in meningitis\/ventriculitis. Nebulized colistin should be used as adjunctive treatment, but not as monotherapy. Nephrotoxicity and apnea were reported in 5.8% and 3.9% of patients respectively.The use of colistin for multidrug-resistant Gram-negative infections in neonates and infants is effective and safe, but the quality of studies is moderate. The optimal intravenous dose should be higher than that indicated in most reports.<\/jats:p>","DOI":"10.1097\/inf.0000000000002448","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T17:50:49Z","timestamp":1567187449000},"page":"1107-1112","source":"Crossref","is-referenced-by-count":34,"title":["The Use of Colistin for the Treatment of Multidrug-resistant Gram-negative Infections in Neonates and Infants"],"prefix":"10.1097","volume":"38","author":[{"given":"Narongsak","family":"Nakwan","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hat Yai Medical Education Centre, Hat Yai Hospital, Songkhla, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kulkanya","family":"Chokephaibulkit","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Imberti","sequence":"additional","affiliation":[{"name":"Phase I Clinical Trials Unit and Experimental Therapy, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20240429","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant gram-negative bacterial infections.","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"R2-20240429","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/jac\/dkn530","article-title":"Efficacy of colistin combination therapy in a mouse model of pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.","volume":"63","author":"Aoki","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"R3-20240429","first-page":"119","article-title":"Colistin inhibits E. coli O157:H7 shiga-like toxin release, binds endotoxins and protects vero cells.","volume":"39","author":"Percivalle","year":"2016","journal-title":"New Microbiol"},{"key":"R4-20240429","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge.","volume":"387","author":"Laxminarayan","year":"2016","journal-title":"Lancet"},{"key":"R5-20240429","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/QCO.0000000000000371","article-title":"Antimicrobial-resistant gram-negative infections in neonates: burden of disease and challenges in treatment.","volume":"30","author":"Folgori","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"R6-20240429","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2807\/ese.13.47.19045-en","article-title":"Emergence of extensively drug-resistant and pandrug-resistant gram-negative bacilli in Europe.","volume":"13","author":"Souli","year":"2008","journal-title":"Euro Surveill"},{"key":"R7-20240429","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"R8-20240429","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jhin.2017.05.025","article-title":"Risk factors and clinical outcomes for carbapenem-resistant gram-negative late-onset sepsis in a neonatal intensive care unit.","volume":"97","author":"Nour","year":"2017","journal-title":"J Hosp Infect"},{"key":"R9-20240429","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1179\/146532809X440761","article-title":"Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intravenous and intraventricular colistin.","volume":"29","author":"Dalgic","year":"2009","journal-title":"Ann Trop Paediatr"},{"key":"R10-20240429","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1442-200X.2009.03015.x","article-title":"Colistimethate sodium therapy for multidrug-resistant isolates in pediatric patients.","volume":"52","author":"Celebi","year":"2010","journal-title":"Pediatr Int"},{"key":"R11-20240429","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00431-009-1137-3","article-title":"Colistin administration to pediatric and neonatal patients.","volume":"169","author":"Iosifidis","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R12-20240429","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.annfar.2011.07.008","article-title":"[Intraventricular colistin use in neonatal meningitis caused by Acinetobacter baumannii].","volume":"30","author":"Alaoui","year":"2011","journal-title":"Ann Fr Anesth Reanim"},{"key":"R13-20240429","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/INF.0b013e3182064bfe","article-title":"Intravenous colistin administration in neonates.","volume":"30","author":"Jajoo","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20240429","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ppul.21324","article-title":"Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report.","volume":"46","author":"Nakwan","year":"2011","journal-title":"Pediatr Pulmonol"},{"key":"R15-20240429","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00431-011-1537-z","article-title":"Outcome of ventilator-associated pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa treated with aerosolized colistin in neonates: a retrospective chart review.","volume":"171","author":"Celik","year":"2012","journal-title":"Eur J Pediatr"},{"key":"R16-20240429","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/0886022X.2012.761084","article-title":"Acquired bartter-like syndrome associated with colistin use in a preterm infant.","volume":"35","author":"Cakir","year":"2013","journal-title":"Ren Fail"},{"key":"R17-20240429","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1055\/s-0034-1371361","article-title":"Efficacy and safety of intravenous colistin in preterm infants with nosocomial sepsis caused by Acinetobacter baumannii.","volume":"31","author":"Alan","year":"2014","journal-title":"Am J Perinatol"},{"key":"R18-20240429","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ppul.22750","article-title":"Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity.","volume":"49","author":"Kang","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"R19-20240429","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.5812\/ijp.453","article-title":"Safety and efficacy of intravenous colistin in neonates with culture proven sepsis.","volume":"25","author":"Serafettin Tekgunduz","year":"2015","journal-title":"Iran J Pediatr"},{"key":"R20-20240429","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12941-016-0126-4","article-title":"Intravenous colistin in the treatment of multidrug-resistant Acinetobacter in neonates.","volume":"15","author":"Al-Lawama","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R21-20240429","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/INF.0000000000001743","article-title":"Persistent gram-negative neurosurgical meningitis in a neonate, successfully treated with intraventricular colistin: Case report and review of the literature.","volume":"37","author":"Al Yazidi","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"R22-20240429","doi-asserted-by":"crossref","first-page":"548","DOI":"10.12659\/MSM.898213","article-title":"Use of colistin in a neonatal intensive care unit: a cohort study of 65 patients.","volume":"23","author":"\u00c7a\u011fan","year":"2017","journal-title":"Med Sci Monit"},{"key":"R23-20240429","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.pedneo.2016.10.002","article-title":"Colistin use in critically ill neonates: a case-control study.","volume":"58","author":"\u0130pek","year":"2017","journal-title":"Pediatr Neonatol"},{"key":"R24-20240429","first-page":"1157","article-title":"Use of colistin for the treatment of multi drug resistant isolates in neonates.","volume":"67","author":"Choudhry","year":"2017","journal-title":"J Pak Med Assoc"},{"key":"R25-20240429","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s40272-018-0301-5","article-title":"Efficacy and safety of intravenous colistin in very low birth weight preterm infants.","volume":"20","author":"Ilhan","year":"2018","journal-title":"Paediatr Drugs"},{"key":"R26-20240429","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/INF.0000000000001263","article-title":"Pharmacokinetics of colistin following a single dose of intravenous colistimethate sodium in critically ill neonates.","volume":"35","author":"Nakwan","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R27-20240429","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1097\/INF.0000000000000775","article-title":"Pulmonary and systemic pharmacokinetics of colistin following a single dose of nebulized colistimethate in mechanically ventilated neonates.","volume":"34","author":"Nakwan","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R28-20240429","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1128\/AAC.01799-09","article-title":"Serum and cerebrospinal fluid levels of colistin in pediatric patients.","volume":"54","author":"Antachopoulos","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"R29-20240429","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00134-007-0675-2","article-title":"Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study.","volume":"33","author":"Kallel","year":"2007","journal-title":"Intensive Care Med"},{"key":"R30-20240429","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/cid\/cit680","article-title":"Consistent global approach on reporting of colistin doses to promote safe and effective use.","volume":"58","author":"Nation","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R31-20240429","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/infdis\/124.4.394","article-title":"Binding of polymyxin antibiotics to tissues: the major determinant of distribution and persistence in the body.","volume":"124","author":"Kunin","year":"1971","journal-title":"J Infect Dis"},{"key":"R32-20240429","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2885.1982.tb00497.x","article-title":"The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves.","volume":"5","author":"Ziv","year":"1982","journal-title":"J Vet Pharmacol Ther"},{"key":"R33-20240429","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"R34-20240429","first-page":"565","article-title":"Dosing guidance for intravenous colistin in critically-ill patients.","volume":"64","author":"Nation","year":"2017","journal-title":"Clin Infect Dis"},{"key":"R35-20240429","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1128\/AAC.01271-08","article-title":"Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?","volume":"53","author":"Souli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R36-20240429","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1179\/joc.2004.16.3.282","article-title":"Microbiological activity and clinical efficacy of a colistin and rifampin combination in multidrug-resistant Pseudomonas aeruginosa infections.","volume":"16","author":"Tascini","year":"2004","journal-title":"J Chemother"},{"key":"R37-20240429","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1128\/AAC.00485-09","article-title":"Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique.","volume":"53","author":"Jin","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R38-20240429","doi-asserted-by":"crossref","first-page":"4907","DOI":"10.1128\/AAC.00345-09","article-title":"Penetration of colistin into cerebrospinal fluid.","volume":"53","author":"Markantonis","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"R39-20240429","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1128\/AAC.01461-12","article-title":"Combined intravenous and intraventricular administration of colistin methanesulfonate in critically ill patients with central nervous system infection.","volume":"57","author":"Ziaka","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"R40-20240429","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1586\/14787210.2014.896740","article-title":"Intraventricular or intrathecal colistin for the treatment of central nervous system infections caused by multidrug-resistant gram-negative bacteria.","volume":"12","author":"Imberti","year":"2014","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R41-20240429","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1128\/AAC.00231-12","article-title":"Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration of colistin methanesulfonate.","volume":"56","author":"Imberti","year":"2012","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T19:01:55Z","timestamp":1714417315000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002448"}},"subtitle":["A Review of the Literature"],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002448","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}